Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease

Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease

Bibliographic Details
Main Authors:	Leonardo Brunetti, Antonio Laghezza, Fulvio Loiodice, Paolo Tortorella, Luca Piemontese
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=1;spage=67;epage=68;aulast=Brunetti

Similar Items

Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors
by: Leonardo Brunetti, et al.
Published: (2020-09-01)

Identification and Characterization of Fatty Acid Amide Hydrolase (FAAH) in Physcomitrella Patens
by: Kinser, Brent, et al.
Published: (2013)

Identification and Characterization of Fatty Acid Amide Hydrolase (FAAH) in Physcomitrella Patens
by: Kinser, Brent, et al.
Published: (2013)

Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes
by: Natalia Battista, et al.
Published: (2007-07-01)

Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization
by: Maddalena Grieco, et al.
Published: (2021-07-01)

Alterations in Fatty Acid Amide Hydrolase (Faah) Transcript Levels and Activity Lead to Changes in the Abiotic Stress Susceptibility of Arabidopsis Thaliana
by: Gonzalez, Gabriel
Published: (2012)

N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
by: Naresh Sunduru, et al.
Published: (2017-01-01)

Die Rolle des Enzyms Fatty Acid Amide Hydrolase (FAAH) und von Varianten des FAAH Gens bei chronisch entzündlichen Darmerkrankungen
by: Emmerdinger, Dominik
Published: (2009)

Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity
by: Rief Winfried, et al.
Published: (2010-01-01)

Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
by: Patricia eRivera, et al.
Published: (2015-03-01)

An innovative approach for the treatment of Alzheimer’s disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventions
by: Luca Piemontese
Published: (2019-01-01)

A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
by: Dale Deutsch
Published: (2016-10-01)

Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents
by: Rosalba Leuci, et al.
Published: (2020-06-01)

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.
by: Claudio D'Addario, et al.
Published: (2012-01-01)

Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists.
by: Marcelo Vizoná Liberato, et al.
Published: (2012-01-01)

Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.
by: Aldric T Hama, et al.
Published: (2014-01-01)

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions
by: Lin Peng, et al.
Published: (2021-01-01)

The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer
by: Runzhi Huang, et al.
Published: (2020-01-01)

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders
by: Min-Chul Cho, et al.
Published: (2008-01-01)

Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis
by: Adner Mikael, et al.
Published: (2005-11-01)

Regulation of peroxisome proliferator-activated receptor-alpha (PPAR#alpha#)
by: Owens, Joanna
Published: (2000)

Effects of the nature compounds on the peroxisome proliferator-activated receptors (PPARs)
by: Kuei-jung Liang, et al.
Published: (2007)

The Effect of Peroxisome Proliferator-Activated Receptors (PPARs) in Male Fertility
by: Motahareh Sadat Mousavi, et al.
Published: (2020-09-01)

(2-Aminobenzothiazole)-Methyl-1,1-Bisphosphonic Acids: Targeting Matrix Metalloproteinase 13 Inhibition to the Bone
by: Antonio Laghezza, et al.
Published: (2021-01-01)

Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases
by: Rosalba Leuci, et al.
Published: (2021-12-01)

Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
by: K Schoonjans, et al.
Published: (1996-05-01)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) <it>in vitro</it>
by: Dionisi Mauro, et al.
Published: (2012-05-01)

Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis
by: Véronique Ferret-Sena, et al.
Published: (2018-06-01)

Peroxisome Proliferator-Activated Receptor (PPAR): Balance for Survival in Parasitic Infections
by: Marion M. Chan, et al.
Published: (2010-01-01)

New Target Genes for the Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Antitumour Activity: Perspectives from the Insulin Receptor
by: Daniela P. Foti, et al.
Published: (2009-01-01)

Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer’s Disease
by: Luca Piemontese, et al.
Published: (2018-08-01)

Characterization of Fatty Acid Amide Hydrolases in Tomato
by: Tiwari, Vijay, et al.
Published: (2016)

Characterization of Fatty Acid Amide Hydrolases in Tomato
by: Tiwari, Vijay, et al.
Published: (2016)

Three-Dimensional Quantitative Structure-Activity Relationships (3D-QSAR) on a Series of Piperazine-Carboxamides Fatty Acid Amide Hydrolase (FAAH) Inhibitors as a Useful Tool for the Design of New Cannabinoid Ligands
by: Marcos Lorca, et al.
Published: (2019-05-01)

Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders
by: Ping Ren, et al.
Published: (2015-01-01)

Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders
by: Ping Ren, et al.
Published: (2015-04-01)

Studies on the identification and function of metabolites involved in peroxisome proliferator-activated receptor (PPAR) α activation
by: Takahashi, Haruya
Published: (2014)

Glycogen content regulates peroxisome proliferator activated receptor-∂ (PPAR-∂) activity in rat skeletal muscle.
by: Andrew Philp, et al.
Published: (2013-01-01)

Peroxisome Proliferators Activated Receptor (PPAR) agonists activate hepatitis B virus replication in vivo
by: Lingyao Du, et al.
Published: (2017-05-01)

Omega 3 polyunsaturated fatty acid improves spatial learning and hippocampal Peroxisome Proliferator Activated Receptors (PPARα and PPARγ) gene expression in rats
by: Hajjar Toktam, et al.
Published: (2012-09-01)